A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response

被引:3
作者
Koch, Jonas P. [1 ,2 ,3 ,4 ]
Roth, Selina M. [2 ]
Quintin, Aurelie [1 ,2 ,3 ]
Gavini, Jacopo [2 ,4 ,5 ]
Orlando, Eleonora [1 ,2 ,3 ,4 ]
Riedo, Rahel [1 ,2 ,3 ]
Pozzato, Chiara [1 ,2 ,3 ]
Hayrapetyan, Liana [1 ,2 ,3 ,4 ]
Aebersold, Ruedi [6 ,7 ]
Stroka, Deborah M. M. [2 ,5 ]
Aebersold, Daniel M. M. [2 ]
Medo, Matus [1 ,2 ,3 ]
Zimmer, Yitzhak [1 ,2 ,3 ]
Medova, Michaela [1 ,2 ,3 ]
机构
[1] Bern Univ Hosp, Dept Biomed Res, Radiat Oncol, Inselspital, Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
[3] Bern Univ Hosp, Dept Radiat Oncol, Inselspital, Freiburgstr 8, CH-3008 Bern, Switzerland
[4] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland
[5] Bern Univ Hosp, Inselspital, Dept Biomed Res, Visceral Surg, Bern, Switzerland
[6] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland
[7] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
DEPENDENT PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; PRECLINICAL EVALUATION; TYROSINE KINASE; INVASIVE-GROWTH; INHIBITOR; CELLS; MECHANISM; CANCER; REPAIR;
D O I
10.1038/s41388-023-02714-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The DNA damage response (DDR) is intertwined with signaling pathways downstream of oncogenic receptor tyrosine kinases (RTKs). To drive research into the application of targeted therapies as radiosensitizers, a better understanding of this molecular crosstalk is necessary. We present here the characterization of a previously unreported MET RTK phosphosite, Serine 1016 (S1016) that represents a potential DDR-MET interface. MET S1016 phosphorylation increases in response to irradiation and is mainly targeted by DNA-dependent protein kinase (DNA-PK). Phosphoproteomics unveils an impact of the S1016A substitution on the overall long-term cell cycle regulation following DNA damage. Accordingly, the abrogation of this phosphosite strongly perturbs the phosphorylation of proteins involved in the cell cycle and formation of the mitotic spindle, enabling cells to bypass a G2 arrest upon irradiation and leading to the entry into mitosis despite compromised genome integrity. This results in the formation of abnormal mitotic spindles and a lower proliferation rate. Altogether, the current data uncover a novel signaling mechanism through which the DDR uses a growth factor receptor system for regulating and maintaining genome stability. [GRAPHICS] .
引用
收藏
页码:2113 / 2125
页数:13
相关论文
共 53 条
  • [11] Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
    Bonner, James A.
    Harari, Paul M.
    Giralt, Jordi
    Cohen, Roger B.
    Jones, Christopher U.
    Sur, Ranjan K.
    Raben, David
    Baselga, Jose
    Spencer, Sharon A.
    Zhu, Junming
    Youssoufian, Hagop
    Rowinsky, Eric K.
    Ang, K. Kian
    [J]. LANCET ONCOLOGY, 2010, 11 (01) : 21 - 28
  • [12] Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
    Burtness, B
    Goldwasser, MA
    Flood, W
    Mattar, B
    Forastiere, AA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8646 - 8654
  • [13] Chatterjee N., 2017, ENVIRON MOL MUTAGEN, V51, P229
  • [14] Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
    Comoglio, Paolo M.
    Trusolino, Livio
    Boccaccio, Carla
    [J]. NATURE REVIEWS CANCER, 2018, 18 (06) : 341 - 358
  • [15] MET inhibition overcomes radiation resistance of glioblastoma stem-like cells
    De Bacco, Francesca
    D'Ambrosio, Antonio
    Casanova, Elena
    Orzan, Francesca
    Neggia, Roberta
    Albano, Raffaella
    Verginelli, Federica
    Cominelli, Manuela
    Poliani, Pietro L.
    Luraghi, Paolo
    Reato, Gigliola
    Pellegatta, Serena
    Finocchiaro, Gaetano
    Perera, Timothy
    Garibaldi, Elisabetta
    Gabriele, Pietro
    Comoglio, Paolo M.
    Boccaccio, Carla
    [J]. EMBO MOLECULAR MEDICINE, 2016, 8 (05) : 550 - 568
  • [16] Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
    De Bacco, Francesca
    Luraghi, Paolo
    Medico, Enzo
    Reato, Gigliola
    Girolami, Flavia
    Perera, Timothy
    Gabriele, Pietro
    Comoglio, Paolo M.
    Boccaccio, Carla
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (08) : 645 - 661
  • [17] A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO
    DIMRI, GP
    LEE, XH
    BASILE, G
    ACOSTA, M
    SCOTT, C
    ROSKELLEY, C
    MEDRANO, EE
    LINSKENS, M
    RUBELJ, I
    PEREIRASMITH, O
    PEACOCKE, M
    CAMPISI, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9363 - 9367
  • [18] The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase
    Fan, SJ
    Ma, YX
    Wang, JA
    Yuan, RQ
    Meng, QH
    Cao, YJ
    Laterra, JJ
    Goldberg, ID
    Rosen, EM
    [J]. ONCOGENE, 2000, 19 (18) : 2212 - 2223
  • [19] Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents
    Fan, SJ
    Wang, JA
    Yuan, RQ
    Rockwell, S
    Andres, J
    Zlatapolskiy, A
    Goldberg, ID
    Rosen, EM
    [J]. ONCOGENE, 1998, 17 (02) : 131 - 141
  • [20] Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer
    Francica, Paola
    Nisa, Lluis
    Aebersold, Daniel M.
    Langer, Rupert
    Bladt, Friedhelm
    Blaukat, Andree
    Stroka, Deborah
    Martinez, Maria Rodriguez
    Zimmer, Yitzhak
    Medova, Michaela
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5322 - 5336